Article Type
Review
Published
This article provides a narrative review on the current non-glycaemic and glycaemic treatment options for cardiovascular risk reduction in patients with Type 2 diabetes and atherosclerotic cardiovascular disease.
Review
This article provides a narrative review on the current non-glycaemic and glycaemic treatment options for cardiovascular risk reduction in patients with Type 2 diabetes and atherosclerotic cardiovascular disease.
Review
This review aims to present and discuss the current clinical and scientific data pertaining to the new and emerging lipid-modifying low-density lipoprotein-cholesterol-lowering drugs.
Review
This review discusses the efficacy and safety of semaglutide, which have
been investigated in an extensive clinical development
program including more than 9,000 patients with type 2
diabetes.
Review
This article reviews the expanding clinical applicability of chloroquine and related drugs includes rheumatological and cardiovascular disorders (CVD), chronic kidney disease (CKD), oncology, and a variety of nonmalarial infections.
Review
This review presents and discusses the current clinical and scientific data pertaining to the therapeutic options for the management of hyperlipoproteinemia (a).